View More Recent Stories

Nov 11, 2024 07:41AM Lantheus Holdings (LNTH) Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

Nov 7, 2024 05:58AM Lantheus Holdings (LNTH) PT Lowered to $122 at Leerink Partners

Nov 6, 2024 08:37AM Lantheus Holdings (LNTH) Tops Q3 EPS by 14c; offers guidance

Sep 30, 2024 03:11PM Truist Securities Reiterates Buy Rating on Lantheus Holdings (LNTH)

Sep 16, 2024 08:55AM TD Cowen Reiterates Buy Rating on Lantheus Holdings (LNTH)

Sep 5, 2024 08:33AM Lantheus Holdings (LNTH) Appoints Julie Eastland to its Board

Sep 3, 2024 04:24AM Redburn-Atlantic Starts Lantheus Holdings (LNTH) at Buy

Jul 31, 2024 07:09AM Lantheus Holdings (LNTH) Misses Q2 EPS by 3c, provides guidance

Jul 26, 2024 05:41AM JMP Securities Reiterates Market Outperform Rating on Lantheus Holdings (LNTH)

Jul 23, 2024 09:11AM Lantheus Holdings (LNTH) PT Raised to $145 at TD Cowen

Jul 18, 2024 12:07PM Lantheus Holdings (LNTH) PT Raised to $137 at Jones Trading

Jul 15, 2024 08:31AM Lantheus Holdings (LNTH) Acquires NAV-4694

Jul 15, 2024 06:40AM Lantheus Holdings (LNTH) PT Raised to $165 at Mizuho

Jul 12, 2024 06:36AM Lantheus Holdings (LNTH) PT Raised to $165 at Mizuho

Jul 11, 2024 07:20AM Lantheus Holdings (LNTH) PT Raised to $141 at Truist Securities

Jul 10, 2024 02:07PM Truist Securities Reiterates Buy Rating on Lantheus Holdings (LNTH)

Jul 10, 2024 10:48AM Lantheus Holdings (LNTH) July 100 calls and August 95 calls as share price up 29%

Jul 8, 2024 08:32AM Lantheus Holdings (LNTH) Appoints Jamie Spaeth as Chief People Officer

Jun 27, 2024 07:05AM Lantheus Holdings (LNTH) Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

View More Recent Stories